9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Crescent Biopharma Partners with Kelun-Biotech, Raises $185M for Therapeutics, Investor Presentation
Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Material Contracts, Completing Asset Acquisition or Sale, Financial Results, Material Modifications to Rights of Security Holders, Changing the Company's Accountant, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Ch
Stockholders Approve Proposed Merger and All Related Proposals
Other Events
News, Material Contracts
FY 2024
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
S-1
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload